Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Direkt zur Navigaton springen.
Direkt zum Inhalt springen.

Navigation/Suche

Schrem Harald Heinrich |

Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen

Oedingen, C; Bartling, T; Schrem, H; Krauth, C TRANSPLANT PHYSICIANS' PREFERENCES IN DECEASED ORGAN ALLOCATION: A PILOT DISCRETE CHOICE EXPERIMENT
VALUE HEALTH. 2023; 26(12): S501-S501.
Web of Science

Wienerroither, V; Hammer, R; Mischinger, H; Schrem, H; Hauser, H; Wagner, D; Kornprat, P; Simon, A; Sucher, R; El-Shabrawi, A LigaSure vs. konventionelle axilläre Lymphknotendissektion beim Mammakarzinom: Eine retrospektive Vergleichsstudie.
Eur Surg Supplement 1. 2023. 2023; (55):S1-S132.-Österr. Chirurgenkongress; June 14-16, 2023; Salzburg. [Oral Communication]

Oedingen, C; Bartling, T; Schrem, H; Muhlbacher, AC; Krauth, C Public Preferences in Organ Allocation: A Discrete Choice Experiment Regarding Distributive Justice
PATIENT. 2022; 15(6):733-733.-28th Annual Meeting of the German Transplantation Society; 19.10.2019; Hannover. [Oral Communication]
Web of Science

Oedingen, C; Bartling, T; Schrem, H; Muhlbacher, AC; Krauth, C PUBLIC PREFERENCES IN ORGAN ALLOCATION: A DISCRETE CHOICE EXPERIMENT REGARDING PRINCIPLES OF DISTRIBUTIVE JUSTICE
VALUE HEALTH. 2022; 25(12): S12-S12.
Web of Science

Talakić, E; Kaufmann-Bühler, AK; Steiner, J; Igrec, J; Kniepeiss, D; Al-Sharafy, S; Kahn, J; Schrem, H; Schoellnast, H; Schemmer, P. Gadoxetic acid enhanced MRI in the early postoperative period after liver transplantation: Is there a correlation between Gadoxetic acid uptake and liver maximum function capacity (LiMAx) assessed with 13C-methacetin breath test?.
Oncologic Imaging Course; JUN 30-JUL 02; Dubrovnik, CROATIA. 2022. [Onlinepräsentation]

Waha, J; Enzensberger, M; Thalhammer, M; Kornprat, P; Mischinger, HJ; Schemmer, P; Schrem, H External Validation of a Prognostic Model for the Prediction of 3-year Mortality and Tumor Recurrence in Patients Undergoing Surgery for Pancreatic Neuroendocrine Neoplasms
49th World Congress of the International Society of Surgery ISS/SIC The World's Congress of Surgery isw2022.org . 2022; -49th World Congress of the International Society of Surgery ISS/SIC; AUG 15-18, 2022; Vienna, AUSTRIA. [Poster]

Belarmino, A; Kniepeiss, D; Fleischhacker, MT; Riedl, R; Mandl-Pohl, A; Muller, H; Schrem, H; Iberer, F; Tscheliessnigg, K; Schemmer, P PREVENTION STRATEGIES AGAINST CMV-INFECTION AFTER LIVER TRANSPLANTATION
TRANSPL INT. 2021; 34: 36-36.-Austrotransplant 2021; OKT 20-22, 2021; Spielberg. [Oral Communication]
Web of Science

Bartling, T; Oedingen, C; Kohlmann, T; Schrem, H; Krauth, C A SYSTEMATIC REVIEW OF PHYSICIANS' AND PATIENTS' PREFERENCES REGARDING THE ALLOCATION OF DECEASED DONOR ORGANS: TO WHAT EXTENT ARE PHYSICIANS ACTING AS ADVOCATES FOR THEIR PATIENTS?
TRANSPLANTATION. 2020; 104(9):S246-S246.-28th International Congress of The-Transplantation-Society (TTS); SEP 13-16, 2020; ELECTR NETWORK. [Oral Communication]
Web of Science

Oedingen, C; Bartling, T; Dierks, ML; Muhlbacher, AC; Schrem, H; Krauth, C SYSTEMATIC REVIEW AND FOCUS GROUP DISCUSSIONS OF PUBLIC PREFERENCES FOR THE ALLOCATION OF DECEASED DONOR ORGANS AS PRELIMINARY WORKS: BUILDING A DISCRETE CHOICE EXPERIMENT EVALUATING PRINCIPLES OF DISTRIBUTIVE JUSTICE
TRANSPLANTATION. 2020; 104(9):S247-S247.-28th International Congress of The-Transplantation-Society (TTS); SEP 13-16, 2020; ELECTR NETWORK. [Oral Communication]
Web of Science

Becker, F; Roberts, KJ; de Nadal, M; Zink, M; Stiegler, P; Pemberger, S; Castellana, TP; Kellner, C; Murphy, N; Kaltenborn, A; Tuffs, A; Amelung, V; Krauth, C; Breidenbach, T; Bayliss, J; Schrem, H INCREASING ORGAN DONATION: EXPERT OPINION FROM AUSTRIA, GERMANY, SPAIN AND THE UK
TRANSPL INT. 2019; 32: 18-19.-28th Annual Congress of the German Transplantation Society 28. Jahrestagung der Deutschen Transplantationsgesellschaft; 17. – 19.10.2019; Hannover, Deutschland. [Oral Communication]
Web of Science

Becker, F; Roberts, KJ; de Nadal, M; Zink, M; Stiegler, P; Pemberger, S; Castellana, TP; Kellner, C; Murphy, N; Kaltenborn, A; Tuffs, A; Amelung, V; Krauth, C; Breidenbach, T; Bayliss, J; Schrem, H INCREASING ORGAN DONATION: A CONSENSUS BETWEEN EXPERTS FROM FOUR DIFFERENT COUNTRIES AND HEALTH CARE SYSTEMS FROM AUSTRIA, GERMANY, SPAIN AND THE UK
TRANSPL INT. 2019; 32: 13-14.-Austrotransplant 2019; 23. - 25. Oktober 2019; Bad Ischl. [Oral Communication]
Web of Science

Emmanouilidis, N; Bagias, G; Stiegler, P; Ringe, B; Alten, TA; Kaltenborn, A; Klempnauer, J; Schrem, H CONSEQUENCES OF ACCEPTING A LEFT VERSUS RIGHT DONOR KIDNEY AND TRANSPLANTING IT EITHER INTO THE LEFT OR RIGHT ILIAC FOSSA
TRANSPL INT. 2019; 32: 44-44.-28. Jahrestagung der Deutschen Transplantationsgesellschaft; 17. – 19.10.2019; Hannover, Deutschland. [Poster]
Web of Science

Emmanouilidis, N; Bagias, G; Stiegler, P; Ringe, BP; Alten, TA; Kaltenborn, A; Klempnauer, J; Schrem, H LEFT VERSUS RIGHT DONOR KIDNEY: OBSERVED CONSEQUENCES OF TRANSPLANTATION EITHER INTO THE LEFT OR RIGHT ILIAC FOSSA
TRANSPL INT. 2019; 32: 15-15.-Austrotransplant 2019 33rd Annual Congress for the Austrian Society for Transplantation, Transfusion and Genetics (Austrotransplant); 23. - 25. Oktober 2019; Bad Ischl. [Oral Communication]
Web of Science

Fuhrlinger, K; Kniepeiss, D; Schrem, H; Mathe, Z; Schemmer, P; Muller, H; Iberer, F; Tscheliessnigg, K LOW-DOSE ATG HAS NO INFLUENCE ON PATIENT SURVIVAL, GRAFT SURVIVAL AND CANCER-FREE SURVIVAL AND IMPROVES RENAL OUTCOME IN PATIENTS WITH COMPROMISED KIDNEY FUNCTION AFTER LIVER TRANSPLANTATION
TRANSPL INT. 2019; 32: 16-16.-33rd Annual Congress for the Austrian Society for Transplantation, Transfusion and Genetics (Austrotransplant); 23. - 25. Oktober 2019; Bad Ischl. [Oral Communication]
Web of Science

Fuhrlinger, K; Kniepeiss, D; Schrem, H; Mathe, Z; Schemmer, P; Muller, H; Iberer, F; Tscheliessnigg, K LOW-DOSE ATG HAS NO INFLUENCE ON PATIENT SURVIVAL, GRAFT SURVIVAL AND CANCER-FREE SURVIVAL AND IMPROVES RENAL OUTCOME IN PATIENTS WITH COMPROMISED KIDNEY FUNCTION AFTER LIVER TRANSPLANTATION
TRANSPL INT. 2019; 32: 24-25.-28th Annual Congress of the German Transplantation Society; 17. – 19.10.2019; Hannover, Deutschland. [Oral Communication]
Web of Science

Fuhrlinger, K; Schrem, H; Kniepeiss, D; Mathe, Z; Schemmer, P; Muller, H; Iberer, F; Tscheliessnigg, K HIGHER PRE-TRANSPLANT KDIGO STAGES INCREASE THE RISK FOR EARLY GRAFT REJECTION EPISODES AFTER LIVER TRANSPLANTATION
TRANSPL INT. 2019; 32: 8-8.-28th Annual Congress of the German Transplantation Society; 17. – 19.10.2019; Hannover, Deutschland. [Oral Communication]
Web of Science

Fuhrlinger, K; Schrem, H; Kniepeiss, D; Mathe, Z; Schemmer, P; Muller, H; Iberer, F; Tscheliessnigg, K HIGHER PRE-TRANSPLANT KDIGO STAGES INCREASE THE RISK FOR EARLY GRAFT REJECTION EPISODES AFTER LIVER TRANSPLANTATION
TRANSPL INT. 2019; 32: 22-22.-33rd Annual Congress for the Austrian Society for Transplantation, Transfusion and Genetics (Austrotransplant); 23. - 25. Oktober 2019; Bad ischl. [Oral Communication]
Web of Science

Kniepeiss, D; Fuhrlinger, K; Schrem, H; Mathe, Z; Schemmer, P; Muller, H; Iberer, F; Tscheliessnigg, K INFECTION SAFETY OF LOW-DOSE ATG INDUCTION IN LIVER TRANSPLANTATION
TRANSPL INT. 2019; 32: 9-9.-28. Jahrestagung der Deutschen Transplantationsgesellschaft, 17. – 19.10.2019, Hannover; 17. – 19.10.2019; Hannover, Deutschland. [Oral Communication]
Web of Science

Kniepeiss, D; Fuhrlinger, K; Schrem, H; Mathe, Z; Schemmer, P; Muller, H; Iberer, F; Tscheliessnigg, K INFECTION SAFETY OF LOW-DOSE ATG INDUCTION IN LIVER TRANSPLANTATION
TRANSPL INT. 2019; 32: 14-14.-33rd Annual Congress for the Austrian Society for Transplantation, Transfusion and Genetics (Austrotransplant); 23. - 25. Oktober 2019; Bad Ischl. [Oral Communication]
Web of Science

Kniepeiss, D; Janout, S; Schrem, H; Mathe, Z; Bachmaier, G; Lackner, C; Fickert, P; Toller, W; Muller, H; Schemmer, P EXCELLENT OUTCOME QUALITY IS NOT DEPENDENT ON A HIGH CASELOAD IN LIVER TRANSPLANTATION
TRANSPL INT. 2019; 32: 30-30.-28. Jahrestagung der Deutschen Transplantationsgesellschaft, 17. – 19.10.2019, Hannover; 17. – 19.10.2019; Hannover, Deutschland. [Poster]
Web of Science

Muller, H; Kahn, J; Rosenkranz, A; Deak, A; Kniepeiss, D; Schrem, H; Mathe, Z; Schemmer, P DUAL KIDNEY TRANSPLANTATION - A SINGLE CENTER EXPERIENCE
TRANSPL INT. 2019; 32: 42-42.-28. Jahrestagung der Deutschen Transplantationsgesellschaft, 17. – 19.10.2019, Hannover; 17. – 19.10.2019; Hannover, Deutschland. [Poster]
Web of Science

Oedingen, C; Bartling, T; Muhlbacher, AC; Schrem, H; Krauth, C PUBLIC PREFERENCES FOR THE ALLOCATION OF DONOR ORGANS FOR TRANSPLANTATION: PRINCIPLES OF DISTRIBUTIVE JUSTICE
TRANSPL INT. 2019; 32: 22-23.-28. Jahrestagung der Deutschen Transplantationsgesellschaft, 17. – 19.10.2019, Hannover; 17. – 19.10.2019; Hannover, Deutschland. [Oral Communication]
Web of Science

Schrem, H; Becker, F; Keith, JR; de Nadal, M; Zink, M; Stiegler, P; Pemberger, S; Castellana, TP; Kellner, C; Kaltenborn, A; Tuffs, A; Amelung, V; Krauth, C; Breidenbach, T; Bayliss, J INCREASING ORGAN DONATION: EXPERT OPINION FROM AUSTRIA, GERMANY, SPAIN AND THE UK
TRANSPL INT. 2019; 32: 278-278.-28. Jahrestagung der Deutschen Transplantationsgesellschaft, Hannover; 17. – 19.10.2019; Hannover, Deutschland. [Oral Communication]
Web of Science

Bouami, SF; Beneke, J; Gwiasda, J; Kaltenborn, A; Koch, HF; Liersch, S; Krauth, C; Richter, N; Leiskau, C; Baumann, U; Klempnauer, J; Schrem, H PROGNOSTIC FACTORS FOR LONG-TERM SURVIVAL >= 15 YEARS AFTER PRIMARY PEDIATRIC LIVER TRANSPLANTATION AFTER POST-MORTAL ORGAN DONATION
TRANSPL INT. 2017; 30: 35-35.
Web of Science

Bouami, SF; Gwiasda, J; Beneke, J; Kaltenborn, A; Suero, EM; Koch, HF; Liersch, S; Krauth, C; Klempnauer, J; Schrem, H PROGNOSTIC FACTORS FOR LONG-TERM SURVIVAL >= 15 YEARS AFTER PRIMARY ADULT LIVER TRANSPLANTATION
TRANSPL INT. 2017; 30: 36-37.
Web of Science

Gwiasda, J; Harries, L; Mix, H; Klempnauer, J; Krauth, C; Amelung, V; Schrem, H; Kaltenborn, A CLINICAL PREDICTORS FOR TREATMENT COSTS PER SURVIVED DAY AFTER LIVER TRANSPLANTATION AND OPTIMIZED RESOURCE ALLOCATION
TRANSPL INT. 2017; 30: 40-40.
Web of Science

Gwiasda, J; Marcheel, I; Kaltenborn, A; Schiffer, M; Guler, F; Klempnauer, U; Schrem, H THE INFLUENCE OF LIVING RELATED AND DECEASED DONOR KIDNEY TRANSPLANTATION ON GRAFT SURVIVAL: A PROPENSITY SCORE MATCHED ANALYSIS
TRANSPL INT. 2017; 30: 410-411.
Web of Science

Gwiasda, J; Schrem, H; Kaltenborn, A Identifying Independent Risk Factors for Graft Loss After Primary Liver Transplantation: A Propensity Score Matched Analysis
AM J TRANSPLANT. 2017; 17: 578-579.
Web of Science

Gwiasda, J; Schrem, H; Richter, N; Klempnauer, J; Kaltenborn, A IDENTIFYING INDEPENDENT RISK FACTORS FOR GRAFT LOSS AFTER PRIMARY LIVER TRANSPLANTATION
TRANSPL INT. 2017; 30: 202-202.
Web of Science

Harries, L; Gwiasda, J; Schrem, H; Kaltenborn, A; Mix, H; Krauth, C; Amelung, V IDENTIFYING INDEPENDENT COST DRIVERS FOR THE FIRST YEAR AFTER LIVER TRANSPLANTATION
TRANSPL INT. 2017; 30: 426-426.
Web of Science

Harries, L; Schrem, H; Christian, K; Amelung, V HIGH COST CASES IN LIVER TRANSPLANTATION - A RETROSPECTIVE INTER-SECTORIAL ANALYSIS OF COST RISING FACTORS
TRANSPL INT. 2017; 30: 41-41.
Web of Science

Hein, J; Schrem, H; Marcheel, IL; Stupak, JV; Qu, Z; Gwiasda, J; Kaltenborn, A; Arelin, V; Grannas, G; Klempnauer, J; Beneke, J PREDICTION OF CHRONIC KIDNEY DISEASE AFTER LIVER TRANSPLANTATION
TRANSPL INT. 2017; 30: 42-42.
Web of Science

Heuft, HG; Gwiasda, J; Stranz, P; Mende, W; Kaltenborn, A; Schrem, H 6 Effects of red blood cell transfusion in patients with surgical intervention for pancreatic cancer
TRANSFUS MED HEMOTH. 2017; 44: 4-4.
Web of Science

Kaltenborn, A; Gutcke, A; Schrem, H; Gwiasda, J Biliary Complications Following Liver Transplantation - Single-Center Experience Over Three Decades and Recent Risk Factors
AM J TRANSPLANT. 2017; 17: 577-577.
Web of Science

Kaltenborn, A; Gwiasda, J; Heits, N; Braun, F; Schrem, H The Glasgow Prognostic Score and Its Variants Predict Mortality in Living Donor but Not in Deceased Donor Liver Transplantation for Hepatocellular Carcinoma: A Double-Center Validation Study
AM J TRANSPLANT. 2017; 17: 434-434.
Web of Science

Kaltenborn, A; Zorn, K; Gwiasda, J; Reichert, B; Becker, T; Braun, F; Klempnauer, J; Schrem, H DEVELOPMENT AND VALIDATION OF A PROGNOSTIC MODEL FOR KIDNEY FUNCTION ONE YEAR AFTER COMBINED PANCREAS AND KIDNEY TRANSPLANTATION
TRANSPL INT. 2017; 30: 241-241.
Web of Science

Littbarski, SA; Kaltenborn, A; Gwiasda, J; Beneke, J; Arelin, V; Schwager, Y; Stupak, JV; Marcheel, IL; Emmanouilidis, N; Jager, MD; Scheumann, GFW; Klempnauer, J; Schrem, H PRE-TRANSPLANT VERSUS EARLY OR LATE POST-TRANSPLANT PARATHYROIDECTOMY IN SHPT KIDNEY TRANSPLANT CANDIDATES
TRANSPL INT. 2017; 30: 29-30.
Web of Science

Marcheel, I; Stupak, J; Gwiasda, J; Kaltenborn, A; Beneke, J; Klempnauer, J; Schrem, H THE INFLUENCE OF LIVING AND DECEASED DONOR KIDNEY TRANSPLANTATION ON GRAFT SURVIVAL: A PROPENSITY SCORE MATCHED ANALYSIS
TRANSPL INT. 2017; 30: 45-45.
Web of Science

Mix, H; Harries, L; Schrem, H; Amelung, V; Krauth, C; Kaltenborn, A; Gwiasda, J COST AND RISK FACTOR ANALYSIS FOR PARTICIPATION IN REHABILITATION PROGRAMS AFTER LIVER TRANSPLANTATION
TRANSPL INT. 2017; 30: 34-34.
Web of Science

Pflugrad, H; Schrader, AK; Tryc, AB; Ding, X; Lanfermann, H; Jackel, E; Schrem, H; Beneke, J; Barg-Hock, H; Klempnauer, J; Weissenborn, K CHRONIC NEUROTOXICITY OF CALCINEURIN INHIBITORS IN PATIENTS AFTER LIVER TRANSPLANTATION
TRANSPL INT. 2017; 30: 17-18.
Web of Science

Stupak, J; Marcheel, IL; Gwiasda, J; Beneke, J; Kaltenborn, A; Bouami, SF; Klempnauer, J; Schrem, H INTRODUCTION OF A PROGNOSTIC MODEL FOR 90-DAY MORTALITY AFTER LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA
TRANSPL INT. 2017; 30: 42-42.
Web of Science

Arelin, V; Schaefer, J; Haller, H; Ackermann, I; Schrem, H Kidney Waitlist Management with Lean Six Sigma.
AM J TRANSPLANT. 2016; 16: 244-244.
Web of Science

Harries, L; Schrem, H; Krauth, C; Eric, AV Interfaces between trans-institutional and trans-sectoral care structures Pathways in transplantation medicine.
INT J INTEGR CARE. 2016; 16: UNSP A30 Doi: 10.5334/ijic.2973
Web of Science FullText FullText_MUG

Arelin, V; Schrem, H; Lehner, F; Gwinner, W; Haller, H; Schiffer, M Prognostic Relevance of Rejection Episodes Detected Within the First 3 Weeks After Kidney Transplantation
AM J TRANSPLANT. 2015; 15:
Web of Science

Kousoulas, L; Vondran, FWR; Klempnauer, J; Schrem, H; Lehner, F RISK-ADJUSTED ANALYSIS OF RELEVANT OUTCOME DRIVERS FOR PATIENTS AFTER MORE THAN TWO KIDNEY TRANSPLANTS
TRANSPL INT. 2015; 28: 559-559.
Web of Science

Kaltenborn, A; Gwiasda, J; Kleine, M; Lehner, F; Schrem, H Type of Arterial Reconstruction Influences Outcome After Liver Transplantation.
TRANSPLANTATION. 2014; 98: 749-749. Doi: 10.1097/00007890-201407151-02558
Web of Science FullText FullText_MUG

Kaltenborn, A; Gwiasda, J; Kleine, M; Lehner, F; Schrem, H Type of Arterial Reconstruction Influences Outcome After Liver Transplantation.
AM J TRANSPLANT. 2014; 14: 749-749.
Web of Science

Kaltenborn, A; Kleine, M; Vogel, A; Klempnauer, J; Schrem, H The Dose Matters: Long-Term Immunosuppression's Influence On De Novo Malignancy After Liver Transplantation.
TRANSPLANTATION. 2014; 98: 161-161. Doi: 10.1097/00007890-201407151-00488
Web of Science FullText FullText_MUG

Kaltenborn, A; Kleine, M; Vogel, A; Klempnauer, J; Schrem, H The Dose Matters: Long-Term Immunosuppression's Influence On De Novo Malignancy After Liver Transplantation.
AM J TRANSPLANT. 2014; 14: 161-161.
Web of Science

Klose, J; Klose, M; Manns, M; Klempnauer, J; Schrem, H INFERIOR OUTCOME OF LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS IN THE MODEL FOR END-STAGE LIVER DISEASE ERA
J HEPATOL. 2014; 60(1): S361-S361. Doi: 10.1016/S0168-8278(14)61025-4
Web of Science FullText FullText_MUG

Schrem, H; Focken, M; Reichert, B; Goldis, A; Manns, M; Kaltenborn, A; Becker, T; Klempnauer, J A New Liver Allocation Score (LivAS) to Facilitate the Weighing of Urgency Against Utility in Liver Transplantation
TRANSPLANTATION. 2014; 98: 723-723. Doi: 10.1097/00007890-201407151-02464
Web of Science FullText FullText_MUG

Schrem, H; Volz, S; Kaltenborn, A; Lehner, F; Manns, M; Jaeckel, E; Klempnauer, J Institutional Learning Curve With Significant Influence On Results After Liver Transplantation Since Its Establishment as Standard Therapy in 1983.
TRANSPLANTATION. 2014; 98: 739-740. Doi: 10.1097/00007890-201407151-02523
Web of Science FullText FullText_MUG

Kleine, M; Vondran, F; Lehner, F; Klempnauer, J; Schrem, H Development of a Respiratory Risk Score for Prediction of Prolonged Mechanical Ventilation Following Liver Transplantation
TRANSPLANTATION. 2012; 94(10): 397-397. Doi: 10.1097/00007890-201211271-00736
Web of Science FullText FullText_MUG

Reichert, B; Becker, T; Kleine, M; Zachau, L; Johanning, K; Richter, N; Klempnauer, J; Schrem, H Value of the Preoperative SOFT-score, P-SOFT-score, SALT-score and labMELD-score for the Prediction of Short-Term Patient and Graft Survival of High-Risk Liver Transplant Recipients with a Pre-Transplant Labmeld-Score >= 30
TRANSPLANTATION. 2012; 94(10): 419-419. Doi: 10.1097/00007890-201211271-00791
Web of Science FullText FullText_MUG

Reichert, B; Becker, T; Kleine, M; Zachau, L; Schumacher, C; Lehner, F; Klempnauer, J; Schrem, H Massive Blood Transfusion after the First Cut in Liver Transplantation Predicts Renal Outcome and Survival after Transplantation
TRANSPLANTATION. 2012; 94(10): 420-420. Doi: 10.1097/00007890-201211271-00793
Web of Science FullText FullText_MUG

Schrem, H; Reichert, B; Fruhauf, N; Kleine, M; Zachau, L; Becker, T; Lehner, F; Bektas, H; Klempnauer, J Study on the Usefulness of the Extended Donor Criteria Defined by the German Medical Association as a Prognostic Model for Early Outcome after Liver Transplantation
TRANSPLANTATION. 2012; 94(10): 399-399.
Web of Science

Schrem, H; Reichert, B; Fruhauf, N; Zachau, L; Becker, T; Lehner, F; Kleine, M; Klempnauer, J Established Donor Risk Scores from the United States Fail to Predict Short-Term Outcome after Liver Transplantation in a Current European Transplant Setting
TRANSPLANTATION. 2012; 94(10): 399-399.
Web of Science

Schrem, H; Reichert, M; Reichert, B; Becker, T; Lehner, F; Kleine, M; Bektas, H; Johanning, K; Strassburg, CP; Klempnauer, J Value of the SOFA Score as a Predictive Model for Short-Term Survival in High-Risk Liver Transplant Recipients with a Pre-Transplant Labmeld Score >= 30
TRANSPLANTATION. 2012; 94(10): 401-401. Doi: 10.1097/00007890-201211271-00746
Web of Science FullText FullText_MUG

Schrem, H; Speck, M; Vogel, A; Walter, U; Zachau, L; Bektas, H; Lehner, F; Klempnauer, J; Kleine, M Incidence and Prognosis of de Novo Malignancies after Liver Transplantation
TRANSPLANTATION. 2012; 94(10): 428-428. Doi: 10.1097/00007890-201211271-00808
Web of Science FullText FullText_MUG

Schrem, H; Speck, M; Vogel, A; Walter, U; Zachau, L; Bektas, H; Lehner, F; Klempnauer, J; Kleine, M Incidence and Prognosis of de Novo Malignancies after Liver Transplantation
TRANSPLANTATION. 2012; 94(10): 226-226. Doi: 10.1097/00007890-201211271-00421
Web of Science FullText FullText_MUG

Schrem, H; Zachau, L; Lankisch, T; Kousoulas, L; Bektas, H; Lehner, F; Klempnauer, J; Kleine, M Results after Adult Ex Situ Split Liver Transplantation Since 1987 and the Influence of Biliary Complications
TRANSPLANTATION. 2012; 94(10): 403-403. Doi: 10.1097/00007890-201211271-00752
Web of Science FullText FullText_MUG

Schrem, H; Zachau, L; Meyer-Heithuis, C; Kleine, M; Lehner, F; Klempnauer, J Relevant Prognostic Factors for Patient and Graft Survival after Acute Liver Retransplantation
TRANSPLANTATION. 2012; 94(10): 400-400. Doi: 10.1097/00007890-201211271-00745
Web of Science FullText FullText_MUG

Becker, T; Takabe, A; Schrem, H; Ringe, B; Lehner, F; Strassburg, C; Bektas, H; Klempanuer, J EXTENDED RIGHT LIVER GRAFTS OBTAINED BY EX SITU SPLIT CAN BE USED SAFELY FOR PRIMARY AND SECONDARY TRANSPLANTATION IN ADULTS WITH ACCEPTABLE BILIARY MORBIDITY
TRANSPL INT. 2009; 22: 82-82.
Web of Science

Kousoulas, L; Schrem, H; Richter, N; Becker, T; Klempnauer, J; Lehner, F LIVING DONOR LIVER TRANSPLANTATION: EFFECT OF THE TYPE OF LIVER GRAFT DONATION ON DONOR MORTALITY AND MORBIDITY
TRANSPL INT. 2009; 22: 202-202.
Web of Science

Schrem, H; Till, N; Hoy, L; Kleine, M; Bektas, H; Becker, T; Klempnauer, J DEVELOPMENT AND VALIDATION OF A SURGICAL CHALLENGE SCORE WITH SIGNIFICANT IMPACT ON RESULTS AFTER LIVER TRANSPLANTATION
TRANSPL INT. 2009; 22: 196-197.
Web of Science

Takebe, A; Schrem, H; Ringe, B; Lehner, F; Klempnauer, J; Becker, T BENEFICIAL USAGE OF ANATOMICAL FULL-LEFT SPLIT LIVER GRAFT FOR MIDDLEWEIGHT PEDIATRIC RECIPIENT UNDER HIGH URGENCY STATUS
TRANSPL INT. 2009; 22: 49-49.
Web of Science

Barein, M; Schrem, H; Vilsendorf, AMZ; Wohlgemuth, A; Klempnauer, J; Becker, T Biological wound management with Lucilia sericata followed by vaccuum therapy in complicated secondary healing after liver transplantation.
AM J TRANSPLANT. 2007; 7: 544-545.
Web of Science

Schrem, H; Hoy, L; Till, N; Kleine, M; Bektas, H; Becker, T; Klempnauer, J Benchmarking and scoring of surgical confounding factors with influence on results after liver transplantation.
AM J TRANSPLANT. 2007; 7: 553-553.
Web of Science

Vogl, TJ; Hammerstingl, R; Paul, G; Balzer, JO; Schrem, H; Bechstein, WO MR volumetry for the evaluation of liver parenchyma regeneration after surgical resection in patients with liver tumors
RADIOLOGY. 1998; 209P: 216-216.
Web of Science

Schrem, H; Leder, K; Landt, O; Bechstein, WO; Trautwein, C; Hopf, U; Lobeck, H; Neuhaus, P Fibrosing cholestatic hepatitis (FCH) and mutations in the preS-genome of the hepatitis B virus after liver transplantation.
HEPATOLOGY. 1997; 26(4): 747-747.
Web of Science

Schon, MR; Akkoc, N; Schrem, H; Kollmar, O; Krautlein, K; Lemmens, HP; Wolf, S; Tominaga, M; Neuhaus, P Hepatocellular damage due to warm and cold ischemia correlates with activity of alpha-Glutathione-S-Transferase
HEPATOLOGY. 1996; 24(4): 1795-1795.
Web of Science

Schon, MR; Schrem, H; Akkoc, N; Lemmens, HP; Krautlein, K; Kollmar, O; Tominaga, M; Wolf, S; Neuhaus, P Successful pig liver transplantation after 5 hours of normothermic extracorporeal liver perfusion
HEPATOLOGY. 1996; 24(4): 1240-1240.
Web of Science

TRAUTWEIN, C; SCHREM, H; TILLMANN, H; KUBICKA, S; WALKER, D; BOKER, K; PICHLMAYR, R; MANNS, MP ALTERED REGULATORY MECHANISMS WHICH INFLUENCE THE PROTEIN-COMPOSITION OF THE HBV-ENVELOPE BEFORE AND AFTER OLT
HEPATOLOGY. 1995; 22(4): 96-96.
Web of Science

↑ Seitenanfang / Navigation